OUR PRODUCTS

MOBILE APPS

GENERAL INFO

AUPH

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Aurinia Pharmaceuticals (AUPH) Earnings Date & Reports

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AUPH is expected to report earnings to fall 8.31% to 14 cents per share on October 30

Aurinia Pharmaceuticals AUPH Stock Earnings Reports

Q3'25

Est.

$0.15

Q2'25

Beat

by $0.02

Q1'25

Beat

by $0.05

Q4'24

Missed

by $0.02

Q3'24

Beat

by $0.08

The last earnings report on July 31 showed earnings per share of 15 cents, beating the estimate of 14 cents. With 1.05M shares outstanding, the current market capitalization sits at 1.50B.

View a ticker or compare two or three

Compare

AUPH

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For AUPH
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AUPH showed earnings on July 31, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

14315 118 Avenue

Phone

+1 250 708-4272

Employees

300

Web

https://www.auriniapharma.com